Omnicomm Systems, Inc. Appoints Fernando Montero To Its Board Of Directors

FT. LAUDERDALE, FL - June 18, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC market place, today announced the appointment of Fernando Montero to its Board of Directors.

Mr. Montero, who will chair the Board's Audit Committee, has spent many years in various senior financial, operations and executive management positions. He is the President of Mentor Capital Corporation, an investment management firm involved in listed securities and private equity in the United States and Latin America. Prior to his engagement with Mentor Capital Corporation, he was President of Hanseatic Corporation in New York from 1989 to 1997. Mr. Montero was also a former Minister of Energy and Mines of Perœ during the Belaunde Administration. After earning his MBA from the Wharton School of Business at the University of Pennsylvania, Mr. Montero began his career with the Deltec Group and subsequently worked for the World Bank and Lehman Brothers.

"Mr. Montero's appointment to the Board of Directors is yet another example of OmniComm's commitment to maintain a distinguished Board of Directors, supporting our strategy of becoming the EDC company of choice to academic and government institutions, CROs and pharmaceutical, biotechnology and medical device companies," said Cornelis F. Wit, CEO of OmniComm Systems, Inc. "Fernando's experience in guiding finance and operations adds valuable knowledge and perspective to the Board."

About OmniComm
OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments.

OmniComm ranked in the top 150 as one of the fastest revenue growth technology companies in North America during the last 5 years. In a market overview titled "The Promise of Next-Gen eClinical Trial Software" by Forrester Research, OmniComm was given the highest rating among its competitors for industry middleware. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Germany, California, Maryland, New York, North Carolina and Texas.

Safe Harbor Disclaimer
Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm's operations, markets and profitability, actual results could differ materially and adversely from the expected results.

Back